Research

Psilocybin has a restorative effect on neurons in frontal areas of the brain, according to researchers at Yale University

The data firm's projected market size for Canada remains at US$4B

$2M will go towards 18 research projects focusing on cannabis use among BIPOC, 2SLGBTQ+, veterans and individuals living with severe mental illness

Current naming conventions have added confusion to the poorly understood genetic background of the thousands of varieties in existence today

'For the last 12 to 18 months, these drugs are just stronger and stronger,' says BC paramedic

The psychedelic movement is no longer about anecdotes, experts say

Results come from the IMAGEN study, a large sample group tracked over time in 4 European countries

53% of Canadians are worried it’s too easy to overconsume edibles

Cannabis smokers inhale 'significantly' less harmful chemicals than tobacco smokers, but are still not without some risk

Industry advocates praised recommendations to streamline clinical trails and free up the natural health products sector

One hour of nitrous oxide treatment led to weeks-long relief

According to Veterans Affairs Canada, a record number of nearly 16,000 clients were paid back for medical weed

Sharing environment, social and governance data, these reports have gained significant importance in the eyes of Canadian investors

After years of cannabis study at the university, researchers now have dedicated infrastructure and organization

After drinking the psychedelic plant brew together, Jewish-Israeli and Arab-Palestinian participants reported moments of deep connection, unity and oneness

Toronto-based Field Trip launched two new polls that show more people are open to using psychedelics to treat rising pandemic-related mental health issues

With only one approved US university supplying low-quality cannabis for decades, the DEA says it will finally open up licensing

Australis Capital CSO Jason Dyck explains how each type of cannabis is a distinct set of compounds and how zebrafish are contributing to pain research

As active client registrations drop 15%, it's time to remove barriers like taxes in Canada's medical cannabis program, says a leading expert and advocate

Following the successful MAPS study, MDMA-assisted therapy moves closer to becoming approved by the US FDA

Aside from impairment testing, Ontario-based Zentrela wants to work with cannabis producers to generate accurate product claims

Monthly cannabis sales dipped slightly in the shortest month of the year, but daily purchases were up 4%

Study aims to prove safety of psilocybe mushrooms so Canadian regulators can expand access to psychedelic therapy

Identifying specific terpene-cannabinoid combinations can create new ways to improve medical therapy, researchers suggest

Despite ongoing Covid-19 restrictions, data firms and cannabis companies report record sales on the stoner holiday

More alcohol, but not weed, use during youth is associated with thinning in parts of the brain associated with intelligence, impulsivity and risky behaviour

The first head-to-head clinical trial pushes the psychedelic compound closer to becoming a licensed medicine

The resource-rich country produces less emissions than the US, but it's still a big problem that government isn't tracking and firms don't want to talk about

Canadian provinces are slowly easing strict marketing rules to be on par with alcohol and meet broader public policy goals, U of A prof says

Better data would allow researchers to test the effectiveness of regulations and lead to a more robust market overall, experts say

It's essential to test products pre-launch as they can create bad consumer experiences, says Nextleaf Solutions, which just got approved for human trials

Ontario led all provinces in Q4 with $251 million in legal weed sales, according to the OCS's latest quarterly report

Coming of legal age by the day, cannabis's fastest growing consumer demographic is motivated by identity formation, experts say

Early evidence shows LSD promotes social behaviour in rodents, but pharmaceutical research is still a ways off

A recent review suggests natural settings and activities can complement all stages of psychedelic-assisted therapy

Despite new lockdown orders issued in some provinces, recreational weed sales climbed 14.3% in December to $298.4M

Pricing depends on various factors including competition, a spokesperson says, who confirmed no customer data was leaked

Maine-based Desert Harvest is working with university researchers to see if its CBD-aloe vera formula can treat pain more safely and effectively than opioids

While initial research suggests CBD is well-tolerated in pups, even Canopy recommends consulting your vet before starting any cannabis treatment

Led by robust medical markets in Israel and Germany, 13,849 kg of dried flower and 10,494 L of oil was shipped out of country